Officials at Agea Medical said it is closing in on an $8 million funding round.
The Redwood City, Calif.-based medical device company has raised $6 million for its coffers and is close to its goal.
Agea markets a system that uses vapor to ablate uterine cavity tissues. The company develops medical technology to treat excessive menstrual bleeding, a condition the company says impacts 1 in 4 women in the U.S.
In 2011, the company landed a $13.3 million private equity funding round led by medical device giant Covidien.
Company SEC filings did not disclose the investors involved in the current offering.